Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
about
Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsTumor-platelet interaction in solid tumorsInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsHyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.Platelets guide the formation of early metastatic niches.Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer.Correlation between bone metastasis and thrombocytosis in pulmonary adenocarcinoma patients.Significance of platelet count in esophageal carcinomasPretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinomaSignificance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancerChemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection.Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase.Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent ApproachesA humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.Preoperative Peripheral Blood Count in Breast Carcinoma: Predictor of Prognosis or a Routine TestPlasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiationPlatelet count predicts prognosis in operable non-small cell lung cancer.Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patientsPretreatment thrombocytosis as a prognostic factor in metastatic breast cancerCombination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancerFull blood count pattern of pre-chemotherapy breast cancer patients in Lagos, NigeriaThe prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer.Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancerThrombocytosis as a prognostic marker in gastrointestinal cancers.Simple criteria to predict prognosis in colorectal carcinoma based on lymphopenia and thrombocytosis.Paraneoplastic thrombocytosis in gastrointestinal cancer.The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways.Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma.Low Preoperative albumin-to-globulin ratio Predict Poor Survival and Negatively Correlated with Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma.Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?
P2860
Q24623647-1431AA7D-6A7D-4E3D-89CF-6A906AFD67AAQ26853099-4ACDE59D-6D86-49E4-92A7-64C5C3B117FBQ27009534-EB5BAEEF-036B-4122-9956-A5F04FFFF57BQ33245405-875C5AE9-8B29-4EE0-884A-C49C503AB24BQ34002250-48222AD3-FF3C-4C10-9FDF-5D82F0342AEBQ34577000-6DC71C62-C280-4257-89AD-7C2FDD3C8634Q34993775-AC21120D-A997-429D-92E2-5FF21861A81CQ34996025-2F636138-764C-43F3-B1CA-938654008554Q35042007-3F0EBB7F-D45A-4F3A-88AA-707F343F4463Q35534333-C1DE0ABD-B189-4A5D-8360-D39E3B2A7E98Q35651537-4254C577-0EB7-4699-AFC8-06E2077534E5Q35769337-4725009A-8D32-4437-A0B5-6645AD184A24Q35808697-546CD511-52EB-4DD5-BE57-0876D811FF6AQ35870489-FBA9B640-3A24-4A3C-9F47-ABE188BAE4D8Q35966249-6015F8D0-1EE2-4C85-8353-BFEC0889FDE8Q36255936-BA23D1C8-62CC-4034-9DD0-F55928084D71Q36305346-9D21537A-78DF-498B-956E-482985A7552AQ36366925-71627D5F-37DE-4BB8-A033-C6D44C2651FCQ36546082-1738D6B5-D320-4205-89D5-3AE5F9DE0347Q36655507-52906530-E6D5-4564-82C3-8AE3A67AE688Q36900438-3C9A3A64-5619-4CB7-8838-E09C0E3A7BF5Q36964394-1ABB50F2-3B2C-434E-9091-69B03A0A8307Q36999374-D3DCC3FD-CFC5-41A8-9A8C-1D85B211B8DDQ37040591-EF50CB00-E3F0-47DA-8932-C8ABC729958FQ37145231-A620DF5E-DDB9-4DBC-BA65-B48DF6227E20Q37337938-FB34B414-44D0-4A4E-A0CE-353B215B4C18Q37585911-F8E5E88F-A159-4DA1-AA18-CED9F03C874FQ37716591-F542FDD6-35F8-4D1E-9F07-AE295041EDC0Q38190956-6BD83FA0-1CB2-4C16-BD85-00A0B57C2DD4Q38291998-7E54298E-BF12-41C0-A5B1-1AE9AAC139F9Q38823142-2CDA20B4-5ED8-4638-8720-10A29CA22D5CQ38842991-A2582F8D-9700-478E-A20E-E8F4F88D2B30Q39062109-1D621439-EE98-481D-BD81-864DF6B2BE16Q39884763-FD9D9FAE-2D12-4F27-B58E-1132463A2215Q41396133-2401E178-8C14-4C6F-86E9-C2DDB8B4BFCAQ41443734-DB024111-7BAA-4DCB-B8E6-1E688095066BQ43131864-052496B6-30A0-4A11-8DCB-D96A5305C433Q43639793-7064D5C0-37DE-42E8-89C4-2B0160964154Q44040524-E1CE7E51-C7DE-419C-8C49-132539BB1811Q45753071-D4A37C0A-6C58-45C1-B946-C0DD342F9206
P2860
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@en
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@nl
type
label
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@en
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@nl
prefLabel
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@en
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@nl
P2093
P1476
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
@en
P2093
Akihiko Takeda
Gaku Oohira
Hideaki Shimada
Hideki Hayashi
Hisahiro Matsubara
Shin-ichi Okazumi
Takenori Ochiai
Yoshihiro Nabeya
Yoshio Gunji
P304
P356
10.1016/J.JAMCOLLSURG.2004.01.022
P577
2004-05-01T00:00:00Z